• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中央肿瘤学组中达卡巴嗪(NSC - 45388)的I期评估及其他恶性黑色素瘤研究

Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.

作者信息

Johnson R O, Metter G, Wilson W, Hill G, Krementz E

出版信息

Cancer Treat Rep. 1976 Feb;60(2):183-7.

PMID:769971
Abstract

The major toxic effects of DTIC are nausea and vomiting, leukopenia, and thrombocytopenia. It is an effective drug in the treatment of malignant melanoma with better response rates in women than in men. The addition of other drugs to DTIC therapy does not produce a higher response rate. Preliminary results indicate that as an adjuvant to standard surgical therapy DTIC does not appear beneficial to patients with a high risk for recurrence.

摘要

达卡巴嗪的主要毒性作用包括恶心、呕吐、白细胞减少和血小板减少。它是治疗恶性黑色素瘤的一种有效药物,女性的缓解率高于男性。在达卡巴嗪治疗中添加其他药物并不会产生更高的缓解率。初步结果表明,作为标准手术治疗的辅助手段,达卡巴嗪对复发风险高的患者似乎并无益处。

相似文献

1
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.中央肿瘤学组中达卡巴嗪(NSC - 45388)的I期评估及其他恶性黑色素瘤研究
Cancer Treat Rep. 1976 Feb;60(2):183-7.
2
DTIC (NSC-45388) studies in the southwest oncology group.西南肿瘤协作组中达卡巴嗪(NSC - 45388)的研究
Cancer Treat Rep. 1976 Feb;60(2):189-92.
3
Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).东部肿瘤协作组使用达卡巴嗪(NSC - 45388)进行的研究。
Cancer Treat Rep. 1976 Feb;60(2):193-8.
4
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).达卡巴嗪(NSC - 45388)与黑色素瘤联合治疗。I. 达卡巴嗪、卡莫司汀(NSC - 409962)、洛莫司汀(NSC - 79037)、长春新碱(NSC - 67574)及羟基脲(NSC - 32065)的研究
Cancer Treat Rep. 1976 May;60(5):601-9.
5
DTIC (NSC-45388) in malignant melanoma: a perspective.达卡巴嗪(NSC-45388)在恶性黑色素瘤中的应用:综述
Cancer Treat Rep. 1976 Feb;60(2):165-76.
6
Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.达卡巴嗪(NSC - 45388)单药与卡莫司汀(NSC - 409962)加长春新碱(NSC - 67574)治疗转移性恶性黑色素瘤的随机前瞻性试验。
Cancer Treat Rep. 1976 May;60(5):595-600.
7
Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.采用达卡巴嗪、卡莫司汀和长春新碱联合进行细胞毒性化疗治疗转移性皮肤恶性黑色素瘤。
Cancer Treat Rep. 1976 Sep;60(9):1381-3.
8
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.卡介苗免疫疗法联合达卡巴嗪(NSC-45388)治疗恶性黑色素瘤。
Cancer Treat Rep. 1976 Feb;60(2):177-82.
9
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.达卡巴嗪(NSC - 45388)联合化疗用于晚期恶性黑色素瘤、软组织肉瘤和霍奇金病。
Cancer Treat Rep. 1976 Feb;60(2):205-11.
10
Clinical studies with DTIC (NSC-45388) in various malignancies.用达卡巴嗪(NSC - 45388)对各种恶性肿瘤进行的临床研究。
Cancer Treat Rep. 1976 Feb;60(2):213-4.

引用本文的文献

1
The role of chemotherapy in the modern management of melanoma.化疗在黑色素瘤现代治疗中的作用。
Melanoma Manag. 2014 Nov;1(2):173-184. doi: 10.2217/mmt.14.20. Epub 2014 Dec 4.
2
Clinical applications of dendritic cell vaccination in the treatment of cancer.树突状细胞疫苗接种在癌症治疗中的临床应用
Cancer Immunol Immunother. 2004 Apr;53(4):275-306. doi: 10.1007/s00262-003-0432-5. Epub 2003 Nov 26.
3
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.干扰素α2b联合达卡巴嗪治疗转移性恶性黑色素瘤的经验
Med Oncol. 1995 Mar;12(1):35-40. doi: 10.1007/BF01571406.
4
Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusion.CB10 - 277通过24小时持续输注给药的I期药代动力学试验。
Br J Cancer. 1993 Feb;67(2):369-73. doi: 10.1038/bjc.1993.67.
5
A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.达卡巴嗪联合自体骨髓移植治疗实体瘤患者的I期临床及药理学研究
Invest New Drugs. 1993 May-Aug;11(2-3):169-79. doi: 10.1007/BF00874151.
6
[Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].恶性黑色素瘤氮烯咪胺治疗后出现的伴有急性肝营养不良的肝静脉闭塞综合征(作者译)
Klin Wochenschr. 1981 Mar 2;59(5):229-36. doi: 10.1007/BF01476580.
7
Hepatic vascular lesions associated with dacarbazine treatment.与达卡巴嗪治疗相关的肝脏血管病变。
Br Med J (Clin Res Ed). 1981 May 30;282(6278):1744-5. doi: 10.1136/bmj.282.6278.1744.
8
Cancer chemotherapy: past, present, and future--Part I.癌症化疗:过去、现在与未来——第一部分
J Natl Med Assoc. 1984 Aug;76(8):773-84.
9
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.一名接受达卡巴嗪(DTIC)治疗恶性黑色素瘤的患者出现肝衰竭。
J Cancer Res Clin Oncol. 1979;95(3):281-6. doi: 10.1007/BF00410649.